Hydralazine Hydrochloride
- Product NDC
- 77771-182
- 11-digit product format
- 777710182
- Labeler code
- 77771
- Product ID
- 77771-182_bd5f421e-db2b-6f83-e053-2a95a90ab05e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydralazine Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Radha Pharmaceuticals, Inc.
- Application
- ANDA205236
- Marketing category
- ANDA
- Marketing start
- 2021-03-04
- Substance
- HYDRALAZINE HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A205236-001 | HYDRALAZINE HYDROCHLORIDE | HYDRALAZINE HYDROCHLORIDE | 10MG | TABLET / ORAL | AA | 2017-05-26 | |
| A205236-002 | HYDRALAZINE HYDROCHLORIDE | HYDRALAZINE HYDROCHLORIDE | 25MG | TABLET / ORAL | AA | 2017-05-26 | |
| A205236-003 | HYDRALAZINE HYDROCHLORIDE | HYDRALAZINE HYDROCHLORIDE | 50MG | TABLET / ORAL | AA | 2017-05-26 | |
| A205236-004 | HYDRALAZINE HYDROCHLORIDE | HYDRALAZINE HYDROCHLORIDE | 100MG | TABLET / ORAL | AA | 2017-05-26 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A205236-001 | AA |
| A205236-002 | AA |
| A205236-003 | AA |
| A205236-004 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A205236-001 | HYDRALAZINE HYDROCHLORIDE | 10MG | TABLET / ORAL | AA | 2017-05-26 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A205236-002 | HYDRALAZINE HYDROCHLORIDE | 25MG | TABLET / ORAL | AA | 2017-05-26 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A205236-003 | HYDRALAZINE HYDROCHLORIDE | 50MG | TABLET / ORAL | AA | 2017-05-26 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A205236-004 | HYDRALAZINE HYDROCHLORIDE | 100MG | TABLET / ORAL | AA | 2017-05-26 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A205236-001 | AA | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A205236-002 | AA | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A205236-003 | AA | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A205236-004 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | REMEDYREPACK INC. | 0d65e146-83e5-427f-ac06-04c0d8e72cea | 2026-06-09 | Warnings, Adverse reactions | 205236 ANDA205236 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Coupler LLC | 4aa1b3e8-9389-fe2c-e063-6294a90a7fb9 | 2026-02-12 | Warnings, Adverse reactions | 205236 ANDA205236 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Coupler LLC | 41c019e3-7b07-5f12-e063-6294a90a5365 | 2025-10-22 | Warnings, Adverse reactions | 205236 ANDA205236 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Bryant Ranch Prepack | ff2c4d1e-33ee-40d7-955b-d736f0559f39 | 2024-12-03 | Warnings, Adverse reactions | 205236 ANDA205236 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | A-S Medication Solutions | 8ade1ffe-3738-4aa1-b9c7-59f7290600b9 | 2024-08-07 | Warnings, Adverse reactions | 205236 ANDA205236 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | A-S Medication Solutions | a8194ac4-02d5-4aa1-b4e4-a3759f6f64b5 | 2024-08-07 | Warnings, Adverse reactions | 205236 ANDA205236 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | c2638ae6-a210-490f-8389-bbed6a3229c5 | 2024-04-03 | Warnings, Adverse reactions | 205236 ANDA205236 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Bryant Ranch Prepack | 8224aa3d-b1b9-40df-93fd-a91c6a158898 | 2024-02-20 | Warnings, Adverse reactions | 205236 ANDA205236 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Bryant Ranch Prepack | bc37cf50-b18d-467e-bf67-3270faa8332e | 2024-02-05 | Warnings, Adverse reactions | 205236 ANDA205236 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Bryant Ranch Prepack | d5b0165e-9823-470a-8ed0-5c4c8722369d | 2024-02-05 | Warnings, Adverse reactions | 205236 ANDA205236 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Bryant Ranch Prepack | 4d1594dc-376b-44bd-8c0e-5de731dfb7f9 | 2024-02-02 | Warnings, Adverse reactions | 205236 ANDA205236 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Bryant Ranch Prepack | 18dd864f-1e27-4c98-8f21-eaded77a3ed6 | 2024-01-11 | Warnings, Adverse reactions | 205236 ANDA205236 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Bryant Ranch Prepack | e6d4b15e-1407-4783-94e4-9971dea68221 | 2024-01-11 | Warnings, Adverse reactions | 205236 ANDA205236 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Bryant Ranch Prepack | 36499d4b-bcaf-4b49-aa2a-10c3e34550d0 | 2024-01-11 | Warnings, Adverse reactions | 205236 ANDA205236 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Bryant Ranch Prepack | 4985994c-23ab-4409-bab6-5a17db767f13 | 2024-01-11 | Warnings, Adverse reactions | 205236 ANDA205236 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Bryant Ranch Prepack | 162a0c00-4db8-4f8d-9686-be2f8449abd8 | 2024-01-11 | Warnings, Adverse reactions | 205236 ANDA205236 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Bryant Ranch Prepack | 914d5b62-6f9b-4665-8562-689367c36230 | 2023-12-14 | Warnings, Adverse reactions | 205236 ANDA205236 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Bryant Ranch Prepack | d4509f69-e60e-4440-957b-5c2714480335 | 2023-11-27 | Warnings, Adverse reactions | 205236 ANDA205236 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Bryant Ranch Prepack | 62475f78-5410-43c2-a11d-54a8363c3ae1 | 2023-07-25 | Warnings, Adverse reactions | 205236 ANDA205236 |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Radha Pharmaceuticals, Inc. | 149fa857-30ad-451d-b6e2-0000483ccc97 | 2021-03-12 | Warnings, Adverse reactions | 205236 ANDA205236 77771-182 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Hydralazine Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| HYDRALAZINE HYDROCHLORIDE | 10 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| FD171B778Y | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 149fa857-30ad-451d-b6e2-0000483ccc97 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a3137695-e199-b3b3-2950-87a8ac429689 | Product name | 5 | 20260316 |
| e9ed2ee5-d109-4795-bffe-c3b047717749 | Product name | 2 | 20250107 |
| 0284f4a6-db58-dacf-18fe-da73f4aeea88 | Product name | 4 | 20180827 |
| 0ad8bdca-888e-00da-648b-6a4de854a167 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 77771-182-01 | Hydralazine Hydrochloride | 100 in 1 BOTTLE | TABLET | 100 | 1 | |
| 77771-182-10 | Hydralazine Hydrochloride | 1000 in 1 BOTTLE | TABLET | 1000 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 77771-182-01 | EA - Each | 77771-182 | 28767a80-48cb-481c-8b77-b070e6cc9583 | 1 | 2021-04-08 |
| 77771-182-10 | EA - Each | 77771-182 | 03e0efb3-f92b-44e1-adde-6154bd0e5745 | 1 | 2021-04-08 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 905199 | hydrALAZINE HCl 10 MG Oral Tablet | PSN | 149fa857-30ad-451d-b6e2-0000483ccc97 | 1 |
| 905222 | hydrALAZINE HCl 100 MG Oral Tablet | PSN | 149fa857-30ad-451d-b6e2-0000483ccc97 | 1 |
| 905225 | hydrALAZINE HCl 25 MG Oral Tablet | PSN | 149fa857-30ad-451d-b6e2-0000483ccc97 | 1 |
| 905395 | hydrALAZINE HCl 50 MG Oral Tablet | PSN | 149fa857-30ad-451d-b6e2-0000483ccc97 | 1 |
| 905199 | hydralazine hydrochloride 10 MG Oral Tablet | SCD | 149fa857-30ad-451d-b6e2-0000483ccc97 | 1 |
| 905222 | hydralazine hydrochloride 100 MG Oral Tablet | SCD | 149fa857-30ad-451d-b6e2-0000483ccc97 | 1 |
| 905225 | hydralazine hydrochloride 25 MG Oral Tablet | SCD | 149fa857-30ad-451d-b6e2-0000483ccc97 | 1 |
| 905395 | hydralazine hydrochloride 50 MG Oral Tablet | SCD | 149fa857-30ad-451d-b6e2-0000483ccc97 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 77771-182-01 | 77771018201 | 100 TABLET in 1 BOTTLE (77771-182-01) | 100 tablet | 2021-03-04 | 0000-00-00 | No | No | Current |
| 77771-182-10 | 77771018210 | 1000 TABLET in 1 BOTTLE (77771-182-10) | 1000 tablet | 2021-03-04 | 0000-00-00 | No | No | Current |